Practical, highly convergent, asymmetric synthesis of a selective PPARγ modulator

Organic Process Research and Development

Volumn 13, Issue 3, 2009, Pages 525-534

  Maligres, Peter E ^a   Humphrey, Guy R ^a   Marcoux, Jean François ^b   Hillier, Michael C ^c   Zhao, Dalian ^a   Krska, Shane ^a   Grabowski, Edward J J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Novasep Inc (Finorga)   (France)

^c ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66249101202     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op8002882     Document Type: Article

References (51)

1. Zimmet, P.; Alberti, K. G. M. M.; Shaw, J. Nature 2001, 414, 782- 787.
2. Reviews on PPARg and insulin resistance: (a) Olefsky, J. M.; Saltiel, A. R. Trends Endocrinol. Metab. 2000, 11, 362-368.
3. Berger, J.; Wagner, J. A. Diabetes Technol. Ther. 2002, 4, 163.
4. Berger, J.; Moller, D. E. Annu. Rev. Med. 2002, 53, 409-435.
5. Knouff, C.; Auwerx, J. Endocr. Rev. 2004, 25, 899-918.
6. Cantello, B. C. C.; Cawthorne, M. A.; Cottam, G. P.; Duff, P. T.; Haigh, D.; Hindley, R. M.; Lister, C. A.; Smith, S. A.; Thurlby, P. J. Med. Chem. 1994, 37, 3977-3985.
7. Momose, Y.; Meguro, K.; Ikeda, H.; Hatanka, C.; Oi, S.; Sodha, T. Chem. Pharm. Bull. 1991, 39, 1440-1445.
8. (a) Cock, T.-A.; Houten, S. M.; Auwerx, J. EMBO Rep. 2004, 5, 142.
9. Miller, A. R.; Etger, G. J. Expert Opin. Invest. Drugs 2003, 12, 1489-1500.
10. Gurnell, M.; Savage, D. B.; Chatterjee, V. K. K.; O'Rahilly, S. J. Clin. Endocrinol. Metab. 2003, 88, 2412-2421.
11. For examples see;(a) Acton, J. J.; Black, R. M.; Jones, A. B.; Moller, D. E.; Colwell, L.; Doebber, T. W.; MacNaul, K. L.; Berger, J.; Wood, H. B. Bioorg. Med. Chem. Lett. 2005, 15, 357-362.
12. Liu, K.; Black, R. M.; Acton, J. J.; Mosley, R.; Debenham, S.; Abola, R.; Yang, M.; Tschirret-Guth, R.; Jones, B.; Colwell, L.; Liu, C.; Wu, M.; Wang, C. F.; MacNaul, K. L.; McCann, M. E.; Moller, D. E.; Berger, J. P.; Meinke, P. T.; Jones, A. B.; Wood, H. B. Bioorg. Med. Chem. Lett. 2005, 15, 2437-2440.
13. Einstein, M.; Akiyama, T. E.; Castriota, G. A.; Wang, C. F.; McKeever, B.; Mosley, R. T.; Becker, J. W.; Moller, D. E.; Meinke, P. T.; Wood, H. B.; Berger, J. P. Mol. Pharmacol. 2008, 73, 62-74.
14. Liu, W.; Liu, K.; Wood, H. B.; McCann, M. E.; Doebber, T. W.; Chang, C. H.; Akiyama, T. E.; Einstein, M.; Berger, J. P.; Meinke, P. T. J. Med. Chem. 2009, 52. Submitted.
15. (a) Gassman, P. G.; van Bergen, T. G. J. Am. Chem. Soc. 1973, 95, 590-591.
16. Gassman, P. G.; van Bergen, T. G. J. Am. Chem. Soc. 1973, 95, 591-592.
17. Gassman, P. G.; van Bergen, T. G.; Gilbert, D. P.; Cue, B. W., Jr. J. Am. Chem. Soc. 1974, 96, 5495-5508.
18. Gassman, P. G.; van Bergen, T. G. J. Am. Chem. Soc. 1974, 96, 5508- 5512.
19. Gassman, P. G.; Gruetzmacher, G.; van Bergen, T. G. J. Am. Chem. Soc. 1974, 96, 5512-5517.
20. Davies, I. W.; Smitrovich, J. H.; Sidler, R.; Qu, C.; Gresham, V.; Bazaral, C. Tetrahedron 2005, 61, 6425-6437.
21. Hydrazine 11 and (S)-ethyl butyrate were not readily available in bulk quantities at the time of this work.
22. For recent reviews see: (a) Gribble, G. W. J. Chem. Soc., Perkin Trans. I 2000, 1045-1075.
23. Humphrey, G. R.; Kuethe, J. T. Chem. Rev. 2006, 106, 2875-2911.
24. Cacchi, S.; Fabrizi, G. Chem. Rev. 2005, 105, 2873-2920.
25. Zeni, G.; Larock, R. C. Chem. Rev. 2004, 104, 2285-2310.
26. (a) Pindur, U.; Adam, R. J. Heterocycl. Chem. 1988, 25, 1-8.
27. Brown, R. K. In Indoles; Houlihan, W. J., Ed.; Wiley-Interscience: New York, 1972; Part 1, Chapter 2.
28. Coleman, N. A. Organic Syntheses; Wiley & Sons: New York, 1948; Collect. Vol. 1, pp 442-445.
29. Monge, A.; Palop, J. A.; de Cera'in, A. L.; Senador, V.; Martinez- Crespo, F. J.; Sainz, Y.; Narro, S.; Garcia', E.; de Miguel, C.; Gonza'lez, M.; Hamilton, E.; Barker, A. J.; Clarke, E. D.; Greenhow, D. T. J. Med. Chem. 1995, 38, 1786-1792.
30. Jagupolski, T. J. Gen. Chem. USSR 1961, 31, 915-924.
31. Ma, C.; Liu, X.; Li, X.; Flippen-Anderson, J.; Yu, S.; Cook, J. M. J. Org. Chem. 2001, 66, 4525-4542.
32. Arcadi, A.; Cacchi, S.; Marinelli, F. Tetrahedron Lett. 1992, 33, 3915- 3918.
33. (a) Sakamoto, T.; Nagano, T.; Kondo, Y.; Yamanaka, H. Synthesis 1991, 215-218.
34. Mills, K.; Al-Khawaja, I. K.; Al-Saleh, F. S.; Joule, J. A. J. Chem. Soc., Perkin Trans. I 1981, 636-641.
35. Popic, V. V.; Korneev, S. M.; Nikolaev, V. A.; Korobitsyna, I. K. Synthesis 1991, 195-198.
36. Fu, X.; Zhang, S.; Yin, J.; McAllister, T. L.; Jiang, S. A.; Tann, C.- H.; Thiruvengadam, T. K.; Zhang, F. Tetrahedron Lett. 2002, 43, 573- 576.
37. (a) Coe, J. W.; Vetelino, M. G.; Bradlee, M. J. Tetrahedon Lett. 1996, 37, 6045-6048.
38. Carrera, G. M.; Sheppard, G. S. Synlett 1994, 93- 94.
39. Kawasi, M.; Sinhababu, A. K.; Borchardt, R. T. J. Heterocycl. Chem. 1987, 24, 1499-1501.
40. (a) Allais, A.; Meier, J.; Mathieu, J.; Nomine, G.; Peterfalvi, M.; Deraedt, R.; Chifflot, L.; Benzoni, J.; Fournex, R. Eur. J. Med. Chem. 1975, 10, 187-199.
41. Molinaro, C.; Mowat, J.; Gosselin, F.; O'Shea, P. D.; Marcoux, J.-F.; Angelaud, R.; Davies, I. W. J. Org. Chem. 2007, 75, 1856-1858.
42. The low temperature for crystallization was required due to the low melting point of 27.
43. Wong, A.; Kuethe, J. T.; Davies, I. W. J. Org. Chem. 2003, 68, 9865- 9866.
44. Okauchi, T.; Itonaga, M.; Minami, T.; Owa, T.; Kitoh, K.; Yoshino, H. Org. Lett. 2000, 2, 1485-1487.
45. Maligres, P. E.; Krska, S. W.; Humphrey, G. R. Org. Lett. 2004, 6, 3147-3150.
46. Prostenik, M.; Salzman, N. P.; Carter, H. E. J. Am. Chem. Soc. 1955, 77, 1856-1859.
47. (a) Rosnati, V.; Saba, A.; Salimbeni, A. Tetrahedron Lett. 1981, 22, 167-168.
48. Padmanathan, T.; Sultanbawa, M. U. S. J. Chem. Soc. 1963, 4210-4218.
49. Ashby, M. T.; Halpern, J. J. Am. Chem. Soc. 1991, 113, 589-594.
50. The use of higher concentrations of substrates 33 and 34 in the presence of acid resulted in substantial polymerization to polyester-type products.
51. Optical purity of 9 was 93% starting from 10 at 94% ee.